TY  - JOUR
AU  - Santos, Arnoldo
AU  - Martínez-Milla, Juan
AU  - Pérez-Calvo, César
AU  - Ibáñez, Borja
PY  - 2022
DO  - 10.1016/j.jacc.2021.10.030
UR  - http://hdl.handle.net/20.500.12105/15766
LA  - eng
PB  - Elsevier
KW  - COVID-19
KW  - Metoprolol
KW  - Administration, Intravenous
KW  - Adrenergic beta-1 Receptor Antagonists
KW  - Humans
KW  - SARS-CoV-2
TI  - Reply: Biological Plausibility Behind the Benefits of Intravenous Metoprolol in Severe COVID-19.
TY  - journal article
ER  -